- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AD-206 40mg
Total 4906 results
-
Assistance Publique - Hôpitaux de ParisRecruitingPrimary Sjögren's Syndrome (pSS)France
-
Chong Kun Dang PharmaceuticalCompletedAlzheimer's Disease (AD)Korea, Republic of
-
South China Center For Innovative PharmaceuticalsXiangya Hospital of Central South UniversityCompleted
-
Medtronic CardiovascularCompletedTricuspid Valve Regurgitation | Tricuspid Valve InsufficiencyUnited States
-
Yooyoung Pharmaceutical Co., Ltd.CompletedErosive EsophagitisKorea, Republic of
-
Imperial College LondonRegeneron Pharmaceuticals; Baim Institute for Clinical ResearchWithdrawnMyocardial Infarction | DyslipidemiasUnited Kingdom
-
Albany Medical CollegeWithdrawnPrimary Arteriovenous Fistula FailureUnited States
-
Boryung Pharmaceutical Co., LtdCompletedChronic Kidney DiseaseKorea, Republic of
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Sun Yat-sen UniversitySun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Zhujiang Hospital; Guangzhou...Not yet recruiting
-
Yokohama City UniversityRecruiting
-
International University of Health and WelfareTerminated
-
Jonathan ElmerLaerdal FoundationTerminatedCardiac ArrestUnited States
-
Massachusetts General HospitalNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Depression | Heroin Dependence | Motivational Interviewing | Adherence | MethadoneUnited States
-
Myles WolfNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedKidney DiseaseUnited States
-
Newsoara Biopharma Co., Ltd.RecruitingT2DM (Type 2 Diabetes Mellitus)China
-
Medicines for Malaria VentureQ-Pharm Pty LimitedTerminatedMalaria, FalciparumAustralia
-
Eisai Inc.CompletedRenal ImpairmentUnited States
-
Eisai Inc.Completed
-
Damanhour UniversityAlexandria UniversityCompletedST-segment Elevation Myocardial InfarctionEgypt
-
Addpharma Inc.CompletedOsteoporosisKorea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
Poitiers University HospitalCompletedChronic Plaque PsoriasisFrance
-
Rznomics, Inc.Not yet recruiting
-
TakedaTerminated
-
University of Kansas Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruiting
-
University of MinnesotaWithdrawnAndrogenetic Alopecia | Male Pattern Baldness | Male Pattern Hair LossUnited States
-
Chong Kun Dang PharmaceuticalCompletedEssential Hypertension | HyperlipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
ImmunityBio, Inc.CompletedPancreatic Ductal AdenocarcinomaUnited States
-
Jørgen Bjerggaard JensenActive, not recruitingBladder CancerDenmark
-
TakedaCompletedDiabetes Mellitus | Liver
-
Rhythm Pharmaceuticals, Inc.CompletedBardet-Biedl Syndrome | POMC DeficiencyNetherlands, United States, Germany, Canada, Puerto Rico, United Kingdom
-
IlDong Pharmaceutical Co LtdUnknown
-
Zeria PharmaceuticalCompleted
-
GlaxoSmithKlineCompleted
-
University of ManchesterEnrolling by invitationSARS VirusUnited Kingdom
-
PfizerCompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
Daewon Pharmaceutical Co., Ltd.Unknown
-
GenfitCompletedType II Diabetes MellitusBosnia and Herzegovina, Latvia, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Serbia
-
PfizerCompletedInflammatory Bowel DiseaseChina
-
Dong-A ST Co., Ltd.Completed
-
Yuhan CorporationSeoul National University HospitalCompletedNon-Small Cell Lung CancerKorea, Republic of
-
GenfitCompletedAbdominal Obesity | Atherogenic DyslipidaemiaFrance, Romania, Tunisia
-
Boehringer IngelheimAstellas Pharma IncCompleted
-
KVT-Study GroupYokohama City University; Showa University; Kitasato University; St. Marianna University... and other collaboratorsCompletedHypertension | Chronic Kidney DiseaseJapan
-
Nanjing Zenshine PharmaceuticalsNot yet recruiting
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusChina